Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)

NCT07477769

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

NCT07476378

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Disease Attributes, +22 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Langfang, Hebei, China

View Trial Details

Not yet recruiting

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

NCT07476729

Conditions: B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: St. Anna Kinderspital GmbH Vienna, Austria

Ghent University Hospital Ghent, Belgium

Fakultni Nemocnice V Motole Prague, Czechia

Rigshospitalet Copenhagen, Denmark

View all 20 locations

View Trial Details

Not yet recruiting

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

NCT07477366

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

NCT07476027

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

NCT07474961

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Copenhagen University Hospital - Rigshospitalet Copenhagen, Greater Copenhagen Area, Denmark

Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Not yet recruiting

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

NCT07463781

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High Grade B Cell Lymphoma, +11 more
Locations: SCDU Ematologia - AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria Alessandria, Italy

Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy

USD-TMO Adulti - ASST Spedali Civili di Brescia Brescia, Italy

Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello Palermo, Italy

View Trial Details

Not yet recruiting

Nemtabrutinib, Bortezomib, and Rituximab for WM

NCT07464210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Not yet recruiting

NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy

NCT07462299

Conditions: Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Children's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

NCT07458659

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: King Chulalongkorn Memorial Hospital Bangkok, Pathumwan, Thailand

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions